Penpulimab has picked up a pair of approvals in nasopharyngeal carcinoma (NPC), becoming only the second drug to be cleared ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

Aulostm Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic, today presented positive results from its ...

Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.

28 patients had pure clear cell carcinoma (CCC), 2 had CCC with sarcomatoid features, and 17 patients had other/unknown histology. Metastatic sites included lymph nodes (n = 12), bone (n = 8), lung ...

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...

Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health ...

A group of scientists from the University of the Philippines (UP) Diliman has identified potential biomarkers for lung cancer ...